Stay updated with breaking news from Nasdaq Dcph. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) saw a large increase in short interest in March. As of March 31st, there was short interest totalling 5,700,000 shares, an increase of 6.9% from the March 15th total of 5,330,000 shares. Currently, 11.0% of the company’s stock are sold short. Based on an average trading volume of […]
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) traded down 3.8% during trading on Thursday . The company traded as low as $14.75 and last traded at $14.77. 17,708 shares were traded during trading, a decline of 98% from the average session volume of 814,655 shares. The stock had previously closed at $15.36. Wall Street Analyst […]
Shares of Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) rose 6.6% on Monday . The stock traded as high as $15.53 and last traded at $15.50. Approximately 37,453 shares changed hands during mid-day trading, a decline of 95% from the average daily volume of 825,850 shares. The stock had previously closed at $14.54. Wall Street […]
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating)’s share price fell 8.1% during mid-day trading on Tuesday . The stock traded as low as $14.56 and last traded at $14.67. 357,192 shares traded hands during trading, a decline of 58% from the average session volume of 854,974 shares. The stock had previously closed at $15.96. Analyst […]
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) has been assigned an average rating of “Moderate Buy” from the ten brokerages that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and six have assigned a buy rating to the […]